Back

Effect of bivalirudin vs unfractionated heparin in transcatheter aortic valve implantation with balloon-expandable valves. The BRAVO-3 trial

27 August 2016 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Percutaneous structural heart interventions Percutaneous / endovascular treatment ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Axel Hp Linke

Heart Centre Dresden - Dresden Technical University Hospital, Dresden (Germany)

18 More presentations in this session

Presentation thumbnail
Doctor S. Ramkumar (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Doctor T. Lefevre (Massy, FR)
Abstract Slides
Presentation thumbnail
Doctor R. Scarsini (Verona, IT)
Abstract Slides
Presentation thumbnail
Mr F. Kortlandt (Nieuwegein, NL)
Abstract Slides
Presentation thumbnail
Doctor J. Carmo (Carnaxide, PT)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Percutaneous structural heart interventions

The Event

Event poster

ESC Congress 2016

27 August 2016 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Antithrombotic therapy during TAVI and peri-interventional management of antithrombotic therapy.
28 August 2022
thumbnail
Congress Presentation
Short-Term outcomes using contemporary balloon-expandable valves in transcatheter aortic valve implantation
27 August 2021
thumbnail
Congress Session
ESC Paul Hugenholtz Lecture in Innovation
25 August 2023
thumbnail
Congress Presentation
Pre- and post-dilatation practices in transcatheter aortic valve implantation using self-expanding valves: a systematic review and meta-analysis
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources